Aardvark Therapeutics, Inc. Common Stock (AARD) vs Foghorn Therapeutics Inc. (FHTX)
A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and Foghorn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AARD
Aardvark Therapeutics, Inc. Common Stock
$5.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
FHTX
Foghorn Therapeutics Inc.
$1.97HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AARD vs FHTX
growth of $100 · dividends reinvested · last 2yAARD -63.5% (-39.6%/yr)FHTX -63.8% (-39.8%/yr)AARD compounded faster over this window
AARD FHTX
AARD vs FHTX: by the numbers
- •FHTX is the larger company ($116M vs $110M market cap).
- •Both run net losses; AARD's is the smaller (0.00% vs -175.78% net margin).
Metrics side by side
Valuation
| Metric | AARD | FHTX |
|---|---|---|
| P/S ratio | N/A | 3.15 |
| P/B ratio | 1.47 | N/A |
Profitability
| Metric | AARD | FHTX |
|---|---|---|
| Gross margin | 0.00% | 89.22% |
| Operating margin | 0.00% | -265.64% |
| Net margin | 0.00% | -175.78% |
| ROE | -93.44% | N/A |
| ROIC | -97.99% | -44.81% |
Growth (annualized)
| Metric | AARD | FHTX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 105.83% |
| Total return CAGR (5Y) | N/A | -31.87% |
Go deeper
Dig into the metrics
Aardvark Therapeutics, Inc. Common Stock ROEFoghorn Therapeutics ROEAardvark Therapeutics, Inc. Common Stock operating marginFoghorn Therapeutics operating marginAardvark Therapeutics, Inc. Common Stock revenue growthFoghorn Therapeutics revenue growthAardvark Therapeutics, Inc. Common Stock free cash flowFoghorn Therapeutics free cash flow
Aardvark Therapeutics, Inc. Common Stock & Foghorn Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.